Thyroid disorders being one of the commonest diseases that produce significant burden worldwide, 32% of people suffer from thyroid diseases in India. The American Thyroid Association (ATA) has recommended routine population screening of both sexes at age 35 years and then every five years thereafter for early detection and treatment of Subclinical hypothyroidism (SH). According to the International Classification of Diseases (ICD), SH does not have a separate code, but is typically labelled as “hypothyroidism, unspecified”. As per the data published for a clinical trial, about 90% of the study population with SH have TSH levels between 4 and 10 mIU/L. Around 20-25% of people with normal TSH levels report one or two of these symptoms. The relation between symptoms and biochemical TSH levels remains unclear. Observational data suggest that SH is associated with an increased risk of coronary heart disease, heart failure, and cardiovascular mortality, particularly in those with TSH levels >10 mIU/L. Such associations were not found for most adults with TSH levels of 5-10 mIU/L. So it is very imperative to pass on guidelines over thyroid hormone use in abnormal TSH below 10mIU/L and above 10mIU/L differently. Still abnormality in thyroid gland physiology and biochemical levels of TSH, T3 and T4 are considered as a disorder or disease associated with thyroid. But considering variable presentations of biochemical scenarios in thyroid dysfunctioning with skewed patterns of clinical symptomatology, there is a need to look at this clinical condition in a more rounded way and denote the same as a Thyroid syndrome.

REFERENCES

1. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012 Mar 24;379(9821):1142-54. doi: 10.1016/S0140-6736(11)60276-6.
2. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism and hypertension: fact or myth? - Authors’ reply. Lancet. 2018 Jan 6;391(10115):30. doi: 10.1016/S0140-6736(17)33321-4, PMID 29323655.
3. Deshmukh V, Behl A, Iyer V, Joshi H, Dholye JP, Varthakavi PK. Prevalence, clinical and biochemical profile of subclinical hypothyroidism in the normal population in Mumbai. Indian J Endocrinol Metab. 2013 May;17(3):454-9. doi: 10.4103/2230-8210.111641, PMID 23869302.
4. Maurya H. Thyroid function disorders among the Indian population. Annals Thyroid Res. 2018;4(3):172-3.
5. Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, Abdulazeem H, Aertgeerts B, Beecher D, Brito JP, Farhoumand PD, Singh Ospina N, Rodondi N, van Driel M, Wallace E, Snel M, Okwen PM, Siemieniuk R, Vandvik PO, Kuijpers T, Vermandere M. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019 May 14;365:l2006. doi: 10.1136/bmj.l2006, PMID 31088853.
6. Wang C, Dai X, Zhang D, Liu Z, Huang Q. Jinlida granules improve dysfunction of hypothalamic-pituitary-thyroid axis in diabetic rats induced by STZ. BioMed Res Int. 2018 Jun 6;2018:4764030. doi: 10.1155/2018/4764030, PMID 29984235.
7. Jebasingh KF, Naik D, Thomas N. Subclinical hypothyroidism. Curr Med Issues. 2018 Apr 1;16(2):39. doi: 10.4103/cmi.cmi_18_18.
8. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab. 2016 Jul;20(4):554-7. doi: 10.4103/2230-8210.183454, PMID 27366725.
9. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 2006 Aug 1;91(8):3088-91. doi: 10.1210/jc.2006-0095, PMID 16684827.
10. Chan S, Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol (Oxf). 2015 Mar;82(3):313-26. doi: 10.1111/cen.12605, PMID 25200555.
11. Larisch R, Midgley JEM, Dietrich JW, Hoermann R. Symptomatic relief is related to serum free triiodothyronine concentrations during follow-up in levothyroxine-treated patients with differentiated thyroid cancer. Exp Clin Endocrinol Diabetes. 2018 Oct;126(9):546-52. doi: 10.1055/s-0043-125064, PMID 29396968.
12. Qi J, Lai X, Wang J, Tang H, Ren H, Yang Y, Jin Q, Zhang L, Yu R, Ma G, Su Z, Zhao H, Wang D. Multi-shelled hollow micro-/nanostructures. Chem Soc Rev. 2015;44(19):6749-73. doi: 10.1039/c5cs00344j, PMID 26135708.
13. Fisher AJ, Medaglia JD, Jeronimus BF. Lack of group-to-individual generalizability is a threat to human subjects research. Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6106-15. doi: 10.1073/pnas.1711978115, PMID 29915059.
14. Midgley JEM, Toft AD, Larisch R, Dietrich JW, Hoermann R. Time for a reassessment of the treatment of hypothyroidism. BMC Endocr Disord. 2019;19(1):37. doi: 10.1186/s12902-019-0365-4, PMID 30999905.